.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
US Army
Johnson and Johnson
Fuji
Queensland Health
Moodys
McKinsey
Express Scripts
Accenture
Baxter

Generated: July 20, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074358

« Back to Dashboard
NDA 074358 describes FLURBIPROFEN, which is a drug marketed by Teva, Ivax Sub Teva Pharms, Pliva, Aurolife Pharma Llc, Mylan, Sun Pharm Inds Inc, Theragen, and Bausch And Lomb, and is included in nine NDAs. It is available from seven suppliers. Additional details are available on the FLURBIPROFEN profile page.

The generic ingredient in FLURBIPROFEN is flurbiprofen sodium. There are eleven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the flurbiprofen sodium profile page.

Summary for NDA: 074358

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Analgesics
Anti-inflammatory Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 074358

Suppliers and Packaging for NDA: 074358

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FLURBIPROFEN
flurbiprofen
TABLET;ORAL 074358 ANDA Mylan Pharmaceuticals Inc. 0378-0076 0378-0076-01 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-0076-01)
FLURBIPROFEN
flurbiprofen
TABLET;ORAL 074358 ANDA Mylan Pharmaceuticals Inc. 0378-0093 0378-0093-01 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-0093-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG
Approval Date:Jun 20, 1994TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength100MG
Approval Date:Jun 20, 1994TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
UBS
Baxter
Daiichi Sankyo
US Department of Justice
Dow
Cipla
Queensland Health
Colorcon
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot